Corrigendum: Elevated IFNA1 and suppressed IL12p40 associated with persistent hyperinflammation in COVID-19 pneumonia

Kyeongseok Jeon; Yuri Kim; Shin Kwang Kang; Uni Park; Jayoun Kim; Nanhee Park; Jaemoon Koh; Man-Shik Shim; Minsoo Kim; Youn Ju Rhee; Hyeongseok Jeong; Siyoung Lee; Donghyun Park; Jinyoung Lim; Hyunsu Kim; Na-Young Ha; Hye-Yeong Jo; Sang Cheol Kim; Ju-Hee Lee; Jiwon Shon; Hoon Kim; Yoon Kyung Jeon; Youn-Soo Choi; Hye Young Kim; Won-Woo Lee; Murim Choi; Hyun-Young Park; Woong-Yang Park; Yeon-Sook Kim; Nam-Hyuk Cho

doi:10.3389/fimmu.2023.1175767

Corrigendum: Elevated IFNA1 and suppressed IL12p40 associated with persistent hyperinflammation in COVID-19 pneumonia

Front Immunol. 2023 Mar 8:14:1175767. doi: 10.3389/fimmu.2023.1175767. eCollection 2023.

Authors

Kyeongseok Jeon^{1

2}, Yuri Kim¹, Shin Kwang Kang³, Uni Park^{1

2}, Jayoun Kim⁴, Nanhee Park⁴, Jaemoon Koh⁵, Man-Shik Shim³, Minsoo Kim², Youn Ju Rhee³, Hyeongseok Jeong⁶, Siyoung Lee⁷, Donghyun Park⁷, Jinyoung Lim⁸, Hyunsu Kim⁸, Na-Young Ha⁹, Hye-Yeong Jo¹⁰, Sang Cheol Kim¹⁰, Ju-Hee Lee¹⁰, Jiwon Shon¹¹, Hoon Kim^{11

12}, Yoon Kyung Jeon⁵, Youn-Soo Choi², Hye Young Kim², Won-Woo Lee^{1

2}, Murim Choi², Hyun-Young Park¹³, Woong-Yang Park^{7

8}, Yeon-Sook Kim⁶, Nam-Hyuk Cho^{1

2

14

15

16}

Affiliations

¹ Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Republic of Korea.
² Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
³ Department of Thoracic and Cardiovascular Surgery, Chungnam National University School of Medicine, Deajon, Republic of Korea.
⁴ Medical Research Collaborating Center, Seoul National University Hospital, Seoul, Republic of Korea.
⁵ Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.
⁶ Department of Internal Medicine, Chungnam National University School of Medicine, Deajon, Republic of Korea.
⁷ Geninus Inc., Seoul, Republic of Korea.
⁸ Samsung Genome Institute, Samsung Medical Center, Seoul, Republic of Korea.
⁹ Chungnam National University Hospital, Biomedical Research Institute, Deajon, Republic of Korea.
¹⁰ Division of Healthcare and Artificial Intelligence, Department of Precision Medicine, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.
¹¹ Department of Biohealth Regulatory Science, School of Pharmacy, Sungkyunkwan University, Suwon-si, Gyeonggi-do, Republic of Korea.
¹² Biopharmaceutical Convergence Major, School of Pharmacy, Sungkyunkwan University, Suwon-si, Gyeonggi-do, Republic of Korea.
¹³ Department of Precision Medicine, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.
¹⁴ Institute of Endemic Diseases, Medical Research Center, Seoul National University, Seoul, Republic of Korea.
¹⁵ Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Republic of Korea.
¹⁶ Wide River Institute of Immunology, Seoul National University, Hongcheon, Gangwon-do, Republic of Korea.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1101808.].

Keywords: COVID-19; IFNa; IL-12p40; SARS-CoV-2; inflammation; pneumonia.

Publication types

Published Erratum